Zobrazeno 1 - 10
of 91
pro vyhledávání: '"Hui-Lan, Rao"'
Autor:
Yu Wang, Cai-Qin Wang, Peng Sun, Pan-Pan Liu, Hang Yang, Han-Yu Wang, Hui-Lan Rao, Su Li, Wen-Qi Jiang, Jia-Jia Huang, Zhi-Ming Li
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Patients with extranodal natural killer/T-cell lymphoma (ENKTL), nasal type are benefit from peg-asparaginase, gemcitabine, and methotrexate. Therefore, we conducted a prospective phase II trial using a combination of these drugs as GAD-M regimen in
Externí odkaz:
https://doaj.org/article/319a0f8bfe754136941c20ecea6e94ba
Autor:
Xiao‐Peng Tian, Jun Cai, Shu‐Yun Ma, Yu Fang, Hui‐Qiang Huang, Tong‐Yu Lin, Hui‐Lan Rao, Mei Li, Zhong‐Jun Xia, Tie‐Bang Kang, Dan Xie, Qing‐Qing Cai
Publikováno v:
Cancer Communications, Vol 40, Iss 6, Pp 245-259 (2020)
Abstract Background Adult patients with T‐cell lymphoblastic lymphoma (T‐LBL) are treated with high‐intensity chemotherapy regimens, but the response rate is still unsatisfactory because of frequent drug resistance. We aimed to investigate the
Externí odkaz:
https://doaj.org/article/d879c20c15c549c582d978468f726c29
Autor:
Zai-Shang Li, Antonio Augusto Ornellas, Christian Schwentner, Xiang Li, Alcides Chaux, Georges Netto, Arthur L. Burnett, Yong Tang, JiunHung Geng, Kai Yao, Xiao-Feng Chen, Bin Wang, Hong Liao, Nan Liu, Peng Chen, Yong-Hong Lei, Qi-Wu Mi, Hui-Lan Rao, Ying-Ming Xiao, Qi-Lin Wang, Zi-Ke Qin, Zhuo-Wei Liu, Yong-Hong Li, Zi-Jun Zou, Jun-Hang Luo, Hui Li, Hui Han, Fang-Jian Zhou
Publikováno v:
Cancer Communications, Vol 38, Iss 1, Pp 1-10 (2018)
Abstract Background The 8th American Joint Committee on Cancer tumor–node–metastasis (AJCC-TNM) staging system is based on a few retrospective single-center studies. We aimed to test the prognostic validity of the staging system and to determine
Externí odkaz:
https://doaj.org/article/f8ce9b1ec97a4711aa1965f163907160
Autor:
Li-Yang Hu, Xiao-Lu Xu, Hui-Lan Rao, Jie Chen, Ren-Chun Lai, Hui-Qiang Huang, Wen-Qi Jiang, Tong-Yu Lin, Zhong-Jun Xia, Qing-Qing Cai
Publikováno v:
Chinese Journal of Cancer, Vol 36, Iss 1, Pp 1-11 (2017)
Abstract Background The programmed cell death-1 (PD-1)/programmed cell death-ligand 1 (PD-L1) pathway inhibits the activation of T cells and plays a crucial role in the negative regulation of cellular and humoral immune responses. Diffuse large B-cel
Externí odkaz:
https://doaj.org/article/31ade90af9814fb98574f36ebca3d306
Autor:
Qing-Qing Cai, Dan Xie, Tie-Bang Kang, Li-Yan Song, Guo-Wei Li, Lan Hai, Xue-Yi Pan, Zhong-Jun Xia, Wen-Jun He, Hong-Yi Gao, Ying Zhang, Yi-Rong Jiang, Chang-Lu Hu, Yong Zhu, Xiang-Ling Meng, Ying Zhou, Qiao-Nan Guo, Jun Rao, Zhi-Gang Zhu, Hui Liu, Wei Sang, Cai Sun, Wei Dong, Xiao-Dong Chen, Yue-Rong Shuang, Kun Yi, Xi-Na Lin, Xia Gu, Kun Ru, Qi Sun, Run-Fen Cheng, Qiong-Li Zhai, Chun-Kui Shao, Qiong Liang, Qiong-Lan Tang, Zhi-Hua Li, Bing Liao, Juan Li, Xiao-Liang Lan, Li Liang, Li-Ye Zhong, Fen Zhang, Fang Liu, Mei Li, Hui-Lan Rao, Shu-Yun Ma, Tong-Yu Lin, Hui-Qiang Huang, Xi Zhang, Yan-Hui Liu, Wei-Juan Huang, Liang Wang, Ning Su, Xiao-Peng Tian
Supplementary Figure S8
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a06e2168900fc487ee7a47e8daa6897d
https://doi.org/10.1158/1078-0432.22475070
https://doi.org/10.1158/1078-0432.22475070
Autor:
Qing-Qing Cai, Dan Xie, Tie-Bang Kang, Li-Yan Song, Guo-Wei Li, Lan Hai, Xue-Yi Pan, Zhong-Jun Xia, Wen-Jun He, Hong-Yi Gao, Ying Zhang, Yi-Rong Jiang, Chang-Lu Hu, Yong Zhu, Xiang-Ling Meng, Ying Zhou, Qiao-Nan Guo, Jun Rao, Zhi-Gang Zhu, Hui Liu, Wei Sang, Cai Sun, Wei Dong, Xiao-Dong Chen, Yue-Rong Shuang, Kun Yi, Xi-Na Lin, Xia Gu, Kun Ru, Qi Sun, Run-Fen Cheng, Qiong-Li Zhai, Chun-Kui Shao, Qiong Liang, Qiong-Lan Tang, Zhi-Hua Li, Bing Liao, Juan Li, Xiao-Liang Lan, Li Liang, Li-Ye Zhong, Fen Zhang, Fang Liu, Mei Li, Hui-Lan Rao, Shu-Yun Ma, Tong-Yu Lin, Hui-Qiang Huang, Xi Zhang, Yan-Hui Liu, Wei-Juan Huang, Liang Wang, Ning Su, Xiao-Peng Tian
Supplementary Table S7
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::030a7cc54e88c04956334c6240cebfaf
https://doi.org/10.1158/1078-0432.22475040.v1
https://doi.org/10.1158/1078-0432.22475040.v1
Autor:
Qing-Qing Cai, Dan Xie, Tie-Bang Kang, Li-Yan Song, Guo-Wei Li, Lan Hai, Xue-Yi Pan, Zhong-Jun Xia, Wen-Jun He, Hong-Yi Gao, Ying Zhang, Yi-Rong Jiang, Chang-Lu Hu, Yong Zhu, Xiang-Ling Meng, Ying Zhou, Qiao-Nan Guo, Jun Rao, Zhi-Gang Zhu, Hui Liu, Wei Sang, Cai Sun, Wei Dong, Xiao-Dong Chen, Yue-Rong Shuang, Kun Yi, Xi-Na Lin, Xia Gu, Kun Ru, Qi Sun, Run-Fen Cheng, Qiong-Li Zhai, Chun-Kui Shao, Qiong Liang, Qiong-Lan Tang, Zhi-Hua Li, Bing Liao, Juan Li, Xiao-Liang Lan, Li Liang, Li-Ye Zhong, Fen Zhang, Fang Liu, Mei Li, Hui-Lan Rao, Shu-Yun Ma, Tong-Yu Lin, Hui-Qiang Huang, Xi Zhang, Yan-Hui Liu, Wei-Juan Huang, Liang Wang, Ning Su, Xiao-Peng Tian
Purpose:Adults with T-cell lymphoblastic lymphoma (T-LBL) generally benefit from treatment with acute lymphoblastic leukemia (ALL)-like regimens, but approximately 40% will relapse after such treatment. We evaluated the value of CpG methylation in pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b213781f5ba30c7bc4c3c8d14265f3b
https://doi.org/10.1158/1078-0432.c.6528984
https://doi.org/10.1158/1078-0432.c.6528984
Autor:
Qing-Qing Cai, Dan Xie, Tie-Bang Kang, Li-Yan Song, Guo-Wei Li, Lan Hai, Xue-Yi Pan, Zhong-Jun Xia, Wen-Jun He, Hong-Yi Gao, Ying Zhang, Yi-Rong Jiang, Chang-Lu Hu, Yong Zhu, Xiang-Ling Meng, Ying Zhou, Qiao-Nan Guo, Jun Rao, Zhi-Gang Zhu, Hui Liu, Wei Sang, Cai Sun, Wei Dong, Xiao-Dong Chen, Yue-Rong Shuang, Kun Yi, Xi-Na Lin, Xia Gu, Kun Ru, Qi Sun, Run-Fen Cheng, Qiong-Li Zhai, Chun-Kui Shao, Qiong Liang, Qiong-Lan Tang, Zhi-Hua Li, Bing Liao, Juan Li, Xiao-Liang Lan, Li Liang, Li-Ye Zhong, Fen Zhang, Fang Liu, Mei Li, Hui-Lan Rao, Shu-Yun Ma, Tong-Yu Lin, Hui-Qiang Huang, Xi Zhang, Yan-Hui Liu, Wei-Juan Huang, Liang Wang, Ning Su, Xiao-Peng Tian
Supplementary Figure legend
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7064785e323e14b278d01d8c2ec1ed5a
https://doi.org/10.1158/1078-0432.22475064.v1
https://doi.org/10.1158/1078-0432.22475064.v1
Autor:
Qing-Qing Cai, Li-Yang Hu, Qi-Rong Geng, Jie Chen, Zhen-Hai Lu, Hui-Lan Rao, Qing Liu, Wen-Qi Jiang, Hui-Qiang Huang, Tong-Yu Lin, Zhong-Jun Xia
Publikováno v:
Chinese Journal of Cancer, Vol 35, Iss 1, Pp 1-12 (2016)
Abstract Background In patients with diffuse large B-cell lymphoma (DLBCL), central nervous system (CNS) relapse is uncommon but is nearly always fatal. This study aimed to determine the risk factors for CNS relapse in DLBCL patients and to evaluate
Externí odkaz:
https://doaj.org/article/e2c78f0e54124bcb91222a6909e6f4c5
Autor:
Wen-Jie Chen, Xia Yu, Yu-Qiang Lu, Ruth M. Pfeiffer, Wei Ling, Shang-Hang Xie, Zhi-Cong Wu, Xue-Qi Li, Yu-Ying Fan, Biao-Hua Wu, Kuang-Rong Wei, Hui-Lan Rao, Qi-Hong Huang, Xiang Guo, Ying Sun, Jun Ma, Qing Liu, Allan Hildesheim, Ming-Huang Hong, Yi-Xin Zeng, Ming-Fang Ji, Zhi-wei Liu, Su-Mei Cao
PurposeTo estimate the effectiveness of an Epstein–Barr virus (EBV) serology-based screening program to reduce nasopharyngeal carcinoma (NPC) mortality in a cluster randomized controlled trial in an NPC high-risk population.MethodsSixteen towns in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::101454c77e79bcca9367fea4a5ee8830
https://doi.org/10.1101/2022.08.08.22278523
https://doi.org/10.1101/2022.08.08.22278523